164 related articles for article (PubMed ID: 9676750)
1. AMPA receptor mediated excitotoxicity in neocortical neurons is developmentally regulated and dependent upon receptor desensitization.
Jensen JB; Schousboe A; Pickering DS
Neurochem Int; 1998; 32(5-6):505-13. PubMed ID: 9676750
[TBL] [Abstract][Full Text] [Related]
2. Development of calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured neocortical neurons visualized by cobalt staining.
Jensen JB; Schousboe A; Pickering DS
J Neurosci Res; 1998 Oct; 54(2):273-81. PubMed ID: 9788286
[TBL] [Abstract][Full Text] [Related]
3. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
4. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones.
Rammes G; Swandulla D; Spielmanns P; Parsons CG
Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667
[TBL] [Abstract][Full Text] [Related]
5. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
Donevan SD; Rogawski MA
Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
May PC; Robison PM; Fuson KS
Neurosci Lett; 1999 Mar; 262(3):219-21. PubMed ID: 10218895
[TBL] [Abstract][Full Text] [Related]
7. Cyclothiazide modulates AMPA receptor-mediated increases in intracellular free Ca2+ and Mg2+ in cultured neurons from rat brain.
Hoyt KR; Rajdev S; Fattman CL; Reynolds IJ
J Neurochem; 1995 May; 64(5):2049-56. PubMed ID: 7536804
[TBL] [Abstract][Full Text] [Related]
8. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
Yamada KA; Turetsky DM
Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
[TBL] [Abstract][Full Text] [Related]
9. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Kristensen BW; Noraberg J; Zimmer J
Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
[TBL] [Abstract][Full Text] [Related]
11. Cyclothiazide and AMPA receptor desensitization: analyses from studies of AMPA-induced release of [3H]-noradrenaline from hippocampal slices.
Cowen MS; Beart PM
Br J Pharmacol; 1998 Feb; 123(3):473-80. PubMed ID: 9504388
[TBL] [Abstract][Full Text] [Related]
12. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
Bleakman D; Ballyk BA; Schoepp DD; Palmer AJ; Bath CP; Sharpe EF; Woolley ML; Bufton HR; Kamboj RK; Tarnawa I; Lodge D
Neuropharmacology; 1996; 35(12):1689-702. PubMed ID: 9076748
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.
Ohno K; Okada M; Tsutsumi R; Matsumoto N; Yamaguchi T
Neurochem Int; 1998 Mar; 32(3):265-71. PubMed ID: 9587920
[TBL] [Abstract][Full Text] [Related]
14. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.
Palmer AJ; Lodge D
Eur J Pharmacol; 1993 Jan; 244(2):193-4. PubMed ID: 7679352
[TBL] [Abstract][Full Text] [Related]
15. Association of c-fos mRNA expression and excitotoxicity in primary cultures of mouse neocortical and cerebellar neurons.
Griffiths R; Malcolm C; Ritchie L; Frandsen A; Schousboe A; Scott M; Rumsby P; Meredith C
J Neurosci Res; 1997 Jun; 48(6):533-42. PubMed ID: 9210523
[TBL] [Abstract][Full Text] [Related]
16. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
Johansen TH; Chaudhary A; Verdoorn TA
Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
[TBL] [Abstract][Full Text] [Related]
17. Cyclothiazide unmasks an AMPA-evoked release of arachidonic acid from cultured striatal neurones.
Williams RJ; Glowinski J
J Neurochem; 1996 Oct; 67(4):1551-8. PubMed ID: 8858939
[TBL] [Abstract][Full Text] [Related]
18. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
Pittaluga A; Bonfanti A; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of kainate receptor mediated whole-cell currents in rat cultured cerebellar granule cells.
Savidge JR; Sturgess NC; Bristow DR; Lock EA
Neuropharmacology; 1999 Mar; 38(3):375-82. PubMed ID: 10219975
[TBL] [Abstract][Full Text] [Related]
20. Kainate receptor-mediated activation of the AP-1 transcription factor complex in cultured rat cerebellar granule cells.
Kovács AD; Cebers G; Liljequist S
Brain Res Bull; 2000 May; 52(2):127-33. PubMed ID: 10808083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
